QCG
PRVA icon

Quadrant Capital Group’s Privia Health PRVA Stock Holding History

Quadrant Capital Group’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$579K Sell
22,518
-260
-1% -$6.02K 0.02% 814
2026
Q1 		$469K Buy
22,778
+460
+2% +$10.4K 0.01% 931
2025
Q4 		$529K Buy
22,318
+7,031
+46% +$171K 0.02% 886
2025
Q3 		$381K Sell
15,287
-371
-2% -$7.98K 0.01% 1022
2025
Q2 		$360K Sell
15,658
-669
-4% -$15.5K 0.01% 1049
2025
Q1 		$367K Buy
16,327
+11,472
+236% +$267K 0.01% 950
2024
Q4 		$94.9K Buy
4,855
+511
+12% +$10.1K 0.01% 1082
2024
Q3 		$79.1K Buy
4,344
+292
+7% +$5.57K 0.01% 1211
2024
Q2 		$70.4K Buy
4,052
+720
+22% +$12.8K 0.01% 1214
2024
Q1 		$65.3K Buy
3,332
+2,324
+231% +$49.1K 0.01% 1239
2023
Q4 		$23.2K Sell
1,008
-666
-40% -$14.9K ﹤0.01% 1748
2023
Q3 		$38.5K Buy
1,674
+1,157
+224% +$29.4K ﹤0.01% 1396
2023
Q2 		$13.5K Buy
+517
New +$13.7K ﹤0.01% 1897

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Quadrant Capital Group's PRVA Position: Q2 2026 in Review

Quadrant Capital Group reduced its Privia Health (PRVA) stake by 1.1% in Q2 2026, selling an estimated $6.02K and leaving 22,518 shares worth $579K. The position accounts for 0.02% of the portfolio, ranked #814.

Quadrant Capital Group first reported a position in PRVA in Q2 2023 and has held it in 13 quarters since. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Quadrant Capital Group held 22,518 shares of Privia Health worth $579K as of Q2 2026.
  • Quadrant Capital Group sold 260 Privia Health shares in Q2 2026, an estimated $6.02K.
  • Privia Health made up 0.02% of Quadrant Capital Group's portfolio in Q2 2026, its #814 holding.
  • Quadrant Capital Group first reported a position in Privia Health in Q2 2023 and has held it in 13 quarters since.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.